Amgen Inc.AMGNNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+16.3%
5Y CAGR+10.6%
Year-over-Year Change
Research and development spending
3Y CAGR
+16.3%/yr
vs +4.4%/yr prior
5Y CAGR
+10.6%/yr
Recent acceleration
Acceleration
+11.9pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.7x
Solid growth
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $6.97B | +16.9% |
| 2024 | $5.96B | +24.7% |
| 2023 | $4.78B | +7.9% |
| 2022 | $4.43B | -29.9% |
| 2021 | $6.32B | +50.3% |
| 2020 | $4.21B | +2.2% |
| 2019 | $4.12B | +10.1% |
| 2018 | $3.74B | +4.9% |
| 2017 | $3.56B | -7.2% |
| 2016 | $3.84B | - |